Bayer US Pharmaceuticals’ Sebastian Guth: Designs On A New Decade

Cancer, Cardio And Culture Are Top Of Mind Targets For Tomorrow’s Top Line Growth

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.